Joshua Jennings
Stock Analyst at TD Cowen
(3.18)
# 1,078
Out of 4,996 analysts
70
Total ratings
44.62%
Success rate
3.63%
Average return
Main Sectors:
Stocks Rated by Joshua Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUMA Humacyte | Maintains: Buy | $5 → $3.5 | $1.73 | +102.31% | 3 | Aug 12, 2025 | |
| SENS Senseonics Holdings | Initiates: Buy | $1.25 | $0.46 | +171.74% | 1 | Jul 15, 2025 | |
| AVR Anteris Technologies Global | Initiates: Buy | $15 | $4.29 | +249.65% | 1 | Jan 7, 2025 | |
| PODD Insulet | Maintains: Buy | $264 → $324 | $318.00 | +1.89% | 1 | Jan 3, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $100 → $110 | $98.18 | +12.04% | 7 | Dec 12, 2024 | |
| CBLL CeriBell | Maintains: Buy | $31 → $36 | $11.37 | +216.62% | 2 | Dec 9, 2024 | |
| TMDX TransMedics Group | Maintains: Buy | $175 → $120 | $113.87 | +5.38% | 9 | Nov 18, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $50 | $2.09 | +2,292.34% | 1 | Oct 2, 2024 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $75 → $99 | $36.66 | +170.05% | 3 | Sep 16, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Hold | $143 → $119 | $98.24 | +21.13% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $60 | $30.23 | +98.48% | 2 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $83 → $80 | $77.98 | +2.59% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $45 | $14.48 | +210.77% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $100 → $70 | $76.25 | -8.20% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $185 | $179.71 | +2.94% | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 | $21.98 | +81.98% | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $365 → $400 | $369.02 | +8.40% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $60 | $39.11 | +53.41% | 4 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $34 | $12.00 | +183.33% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $18 | $5.22 | +244.83% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $114 → $125 | $67.10 | +86.29% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $25 | $17.89 | +39.74% | 1 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $130 | $133.55 | -2.66% | 9 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $5 | $2.94 | +70.07% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $117 | $94.22 | +24.18% | 3 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $450 | $5.46 | +8,141.76% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $12 | $15.02 | -20.11% | 1 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $306 → $275 | $184.60 | +48.97% | 1 | Feb 7, 2020 |
Humacyte
Aug 12, 2025
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.73
Upside: +102.31%
Senseonics Holdings
Jul 15, 2025
Initiates: Buy
Price Target: $1.25
Current: $0.46
Upside: +171.74%
Anteris Technologies Global
Jan 7, 2025
Initiates: Buy
Price Target: $15
Current: $4.29
Upside: +249.65%
Insulet
Jan 3, 2025
Maintains: Buy
Price Target: $264 → $324
Current: $318.00
Upside: +1.89%
Boston Scientific
Dec 12, 2024
Maintains: Buy
Price Target: $100 → $110
Current: $98.18
Upside: +12.04%
CeriBell
Dec 9, 2024
Maintains: Buy
Price Target: $31 → $36
Current: $11.37
Upside: +216.62%
TransMedics Group
Nov 18, 2024
Maintains: Buy
Price Target: $175 → $120
Current: $113.87
Upside: +5.38%
Allurion Technologies
Oct 2, 2024
Initiates: Buy
Price Target: $50
Current: $2.09
Upside: +2,292.34%
PROCEPT BioRobotics
Sep 16, 2024
Maintains: Buy
Price Target: $75 → $99
Current: $36.66
Upside: +170.05%
Zimmer Biomet Holdings
Sep 6, 2024
Maintains: Hold
Price Target: $143 → $119
Current: $98.24
Upside: +21.13%
Aug 27, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $30.23
Upside: +98.48%
Aug 13, 2024
Maintains: Hold
Price Target: $83 → $80
Current: $77.98
Upside: +2.59%
Aug 8, 2024
Maintains: Buy
Price Target: $135 → $45
Current: $14.48
Upside: +210.77%
Jul 25, 2024
Downgrades: Hold
Price Target: $100 → $70
Current: $76.25
Upside: -8.20%
Jul 18, 2024
Maintains: Buy
Price Target: $195 → $185
Current: $179.71
Upside: +2.94%
May 10, 2024
Downgrades: Hold
Price Target: $40
Current: $21.98
Upside: +81.98%
Apr 11, 2024
Maintains: Buy
Price Target: $365 → $400
Current: $369.02
Upside: +8.40%
Mar 12, 2024
Maintains: Outperform
Price Target: $50 → $60
Current: $39.11
Upside: +53.41%
Aug 4, 2023
Maintains: Outperform
Price Target: $52 → $34
Current: $12.00
Upside: +183.33%
May 11, 2023
Maintains: Outperform
Price Target: $14 → $18
Current: $5.22
Upside: +244.83%
Feb 10, 2023
Maintains: Outperform
Price Target: $114 → $125
Current: $67.10
Upside: +86.29%
Dec 30, 2022
Maintains: Outperform
Price Target: $6 → $25
Current: $17.89
Upside: +39.74%
Dec 13, 2022
Maintains: Outperform
Price Target: $130
Current: $133.55
Upside: -2.66%
Nov 11, 2022
Maintains: Outperform
Price Target: $7 → $5
Current: $2.94
Upside: +70.07%
May 27, 2022
Maintains: Outperform
Price Target: $125 → $117
Current: $94.22
Upside: +24.18%
Dec 7, 2021
Initiates: Outperform
Price Target: $450
Current: $5.46
Upside: +8,141.76%
Sep 3, 2020
Initiates: Outperform
Price Target: $12
Current: $15.02
Upside: -20.11%
Feb 7, 2020
Downgrades: Market Perform
Price Target: $306 → $275
Current: $184.60
Upside: +48.97%